top of page

Eyes on Pharma
Check-out What Intel Caught our Eye


Clinical Trial Updates
With blockbuster sales of Caplyta, Johnson & Johnson’s $14.6 billion investment in Intra-Cellular Therapies continues to pay off.

Jana Chisholm
Oct 105 min read


EyesOn Leveraging Clinical Results
Clinical Data Drives Strategic Decisions: Oruka, Boehringer, and Astellas Navigate Risk and Opportunity. Recent trial readouts highlight how clinical outcomes—positive and negative—are shaping portfolio decisions and competitive positioning.

Jana Chisholm
May 312 min read
bottom of page
.png)